otamixaban

Showing 1 posts of 1 posts found.

Sanofi admits $285m failure

June 4, 2013
Research and Development, Sales and Marketing Sanofi, its benzamide iniparib, otamixaban

Sanofi has consigned two investigational drugs to the corporate dustbin, preferring a $285 million dent in its coffers to continuing …

The Gateway to Local Adoption Series

Latest content